ChromaDex Corporation (CDXC)
NASDAQ: CDXC · IEX Real-Time Price · USD
1.60
-0.05 (-3.03%)
Mar 27, 2023, 4:00 PM EDT - Market closed
ChromaDex Market Cap
ChromaDex has a market cap or net worth of $119.74 million as of March 28, 2023. Its market cap has decreased by -28.46% in one year.
Market Cap
119.74M
Enterprise Value
102.44M
1-Year Change
-28.46%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since June 25, 2008, ChromaDex Corporation's market cap has increased from $96.55M to $119.74M, an increase of 24.02%. That is a compound annual growth rate of 1.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 24, 2023 | 119.74M | 2.22% |
Mar 23, 2023 | 117.14M | 9.80% |
Mar 22, 2023 | 106.69M | -4.97% |
Mar 21, 2023 | 112.26M | 3.21% |
Mar 20, 2023 | 108.78M | -1.27% |
Mar 17, 2023 | 110.17M | -3.07% |
Mar 16, 2023 | 113.66M | -2.98% |
Mar 15, 2023 | 117.14M | 1.82% |
Mar 14, 2023 | 115.05M | 3.13% |
Mar 13, 2023 | 111.57M | 8.11% |
Mar 10, 2023 | 103.20M | -9.76% |
Mar 9, 2023 | 114.36M | -10.38% |
Mar 8, 2023 | 127.60M | 12.96% |
Mar 7, 2023 | 112.96M | - |
Mar 6, 2023 | 112.96M | -2.99% |
Mar 3, 2023 | 116.45M | 4.05% |
Mar 2, 2023 | 111.92M | -2.13% |
Mar 1, 2023 | 114.36M | -1.80% |
Feb 28, 2023 | 116.45M | -2.34% |
Feb 27, 2023 | 119.24M | 5.56% |
Feb 24, 2023 | 112.96M | -7.43% |
Feb 23, 2023 | 122.03M | 2.34% |
Feb 22, 2023 | 119.24M | -0.58% |
Feb 21, 2023 | 119.93M | -5.49% |
Feb 17, 2023 | 126.91M | - |
View and export this data all the way back to 2008.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UroGen Pharma Ltd. | 214.67M |
Annexon, Inc. | 206.77M |
CVRx, Inc. | 203.39M |
So-Young International Inc. | 174.80M |
Werewolf Therapeutics, Inc. | 82.95M |
Portage Biotech Inc. | 51.93M |
Checkpoint Therapeutics, Inc. | 44.74M |
BrainsWay Ltd. | 31.76M |
MedAvail Holdings, Inc. | 24.84M |